The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer
- 1 May 1991
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 27 (5), 544-549
- https://doi.org/10.1016/0277-5379(91)90212-v
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Who should measure quality of life, the doctor or the patient?British Journal of Cancer, 1988
- Treating the Patient, Not Just the CancerNew England Journal of Medicine, 1987
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chlorideAmerican Journal Of Medicine, 1987
- Bone metastases: Pathogenesis, treatment, and rationale for use of resorption inhibitorsAmerican Journal Of Medicine, 1987
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987
- Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and biphosphonate treatmentEuropean Journal of Cancer and Clinical Oncology, 1986
- Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myelomaCancer, 1985
- The quality of life of cancer patients: A review of the literatureSocial Science & Medicine, 1985
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983